FPILIM 📈 Formuepleje Limittellus - Overview
Exchange: CO • Country: Denmark • Currency: DKK • Type: Common Stock •
FPILIM: Wealth, Management, Investment, Funds, Securities
Formuepleje Limittellus is headquartered in Hellerup, Denmark. Web URL: https://www.formuepleje.dk
Additional Sources for FPILIM Stock
FPILIM Stock Overview
| Market Cap in USD | 141m |
| GiC Sub-Industry | Coal & Consumable Fuels |
| IPO / Inception |
FPILIM Stock Ratings
| Growth 5y | 58.7% |
| Fundamental | -6.66% |
| Dividend | - |
| Rel. Strength Industry | 7909 |
| Analysts | - |
| Fair Price Momentum | 280.43 DKK |
| Fair Price DCF | 0.04 DKK |
FPILIM Dividends
No Dividends PaidFPILIM Growth Ratios
| Growth Correlation 3m | 68.5% |
| Growth Correlation 12m | 95.4% |
| Growth Correlation 5y | 77% |
| CAGR 5y | 7.49% |
| CAGR/Mean DD 5y | 1.00 |
| Sharpe Ratio 12m | 0.94 |
| Alpha | -3.29 |
| Beta | 0.66 |
| Volatility | 10.98% |
| Current Volume | 14.3k |
| Average Volume 20d | 2.9k |
What is the price of FPILIM stocks?
As of December 22, 2024, the stock is trading at DKK 283.90 with a total of 14,281 shares traded.
Over the past week, the price has changed by -2.96%, over one month by +0.26%, over three months by +1.49% and over the past year by +16.67%.
As of December 22, 2024, the stock is trading at DKK 283.90 with a total of 14,281 shares traded.
Over the past week, the price has changed by -2.96%, over one month by +0.26%, over three months by +1.49% and over the past year by +16.67%.
Is Formuepleje Limittellus a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Formuepleje Limittellus is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -6.66 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of FPILIM as of December 2024 is 280.43. This means that FPILIM is currently overvalued and has a potential downside of -1.22%.
Neither. Based on ValueRay Fundamental Analyses, Formuepleje Limittellus is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -6.66 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of FPILIM as of December 2024 is 280.43. This means that FPILIM is currently overvalued and has a potential downside of -1.22%.
Is FPILIM a buy, sell or hold?
Formuepleje Limittellus has no consensus analysts rating.
Formuepleje Limittellus has no consensus analysts rating.
What are the forecast for FPILIM stock price target?
According to ValueRays Forecast Model, FPILIM Formuepleje Limittellus will be worth about 308.5 in December 2025. The stock is currently trading at 283.90. This means that the stock has a potential upside of +8.67%.
According to ValueRays Forecast Model, FPILIM Formuepleje Limittellus will be worth about 308.5 in December 2025. The stock is currently trading at 283.90. This means that the stock has a potential upside of +8.67%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 308.5 | 8.7% |